Mast	NN
cell	NN
chymase	NN
:	:
an	DT
indispensable	JJ
instrument	NN
in	IN
the	DT
pathological	JJ
symphony	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
?	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
,	,
progressive	JJ
and	CC
fatal	JJ
lung	NN
disease	NN
with	IN
no	DT
known	JJ
etiology	NN
and	CC
treatment	NN
options	NNS
.	.

The	DT
hallmarks	NNS
of	IN
the	DT
histopathology	NN
,	,
which	WDT
is	VBZ
characteristic	JJ
of	IN
usual	JJ
interstitial	JJ
pneumonia	NN
(	(
UIP	NN
)	)
pattern	NN
,	,
include	VBP
interstitial	JJ
fibrosis	NN
,	,
honeycomb	NN
changes	NNS
and	CC
fibroblast	NN
foci	NNS
that	WDT
develop	VBP
owing	VBG
to	TO
fibroblast	NN
proliferation	NN
and	CC
excessive	JJ
matrix	NN
deposition	NN
.	.

Although	IN
the	DT
complete	JJ
pathomechanism	NN
is	VBZ
not	RB
yet	RB
understood	VBN
,	,
several	JJ
molecular	JJ
culprits	NNS
,	,
including	VBG
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
,	,
Angiotensin	NN
(	(
Ang	NN
)	)
II	CD
,	,
endothelin	NN
(	(
ET	NNP
)	)
-1	CD
,	,
matrix	NN
metalloproteinases	NNS
(	(
MMPs	NNS
)	)
and	CC
cytokines	NNS
have	VBP
been	VBN
identified	VBN
.	.

IPF	NN
is	VBZ
increasingly	RB
believed	VBN
to	TO
be	VB
an	DT
epithelial-driven	JJ
disease	NN
;	:
however	RB
,	,
the	DT
literature	NN
does	VBZ
support	VB
an	DT
implication	NN
of	IN
altered	JJ
immune	JJ
response	NN
and	CC
inflammatory	JJ
processes	NNS
in	IN
the	DT
onset	NN
or	CC
progression	NN
of	IN
the	DT
disease	NN
.	.

Mast	NN
cells	NNS
(	(
MCs	NNS
)	)
are	VBP
multifunctional	JJ
tissue	NN
resident	NN
cells	NNS
involved	VBN
in	IN
the	DT
inflammatory	JJ
and	CC
immune	JJ
response	NN
.	.

An	DT
increasing	VBG
body	NN
of	IN
evidence	NN
suggests	VBZ
a	DT
role	NN
of	IN
MCs	NNS
and	CC
their	PRP$
mediator	NN
chymase	NN
in	IN
the	DT
pathology	NN
of	IN
IPF	NN
.	.

With	IN
regard	NN
to	TO
the	DT
underlying	JJ
mechanisms	NNS
,	,
it	PRP
is	VBZ
conceivable	JJ
that	IN
MC	NNP
chymase	NN
may	MD
function	VB
via	IN
activation	NN
or	CC
processing	NN
of	IN
factors	NNS
such	JJ
as	IN
proteases	NNS
,	,
cytokines	NNS
and	CC
growth	NN
factors	NNS
.	.

In	IN
this	DT
review	NN
,	,
we	PRP
will	MD
discuss	VB
how	WRB
MC	NNP
chymase	NN
is	VBZ
linked	VBN
to	TO
and	CC
can	MD
potentially	RB
contribute	VB
to	TO
the	DT
development	NN
of	IN
IPF	NN
.	.

Moreover	RB
,	,
the	DT
findings	NNS
from	IN
animal	NN
model	NN
studies	NNS
will	MD
be	VB
discussed	VBN
to	TO
highlight	VB
the	DT
chymase	NN
inhibitors	NNS
as	IN
a	DT
promising	JJ
strategy	NN
for	IN
the	DT
treatment	NN
of	IN
pulmonary	JJ
fibrosis	NN
.	.

